Effect of nerve degeneration by 6-hydroxydopamine on catecholamine-stimulated adenosine 3',5'-monophosphate formation in rat cerebral cortex.
D000818:Animals; D002250:Carbon Radioisotopes; D002395:Catecholamines / Q000494:pharmacology*; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism*; D002552:Cerebral Ventricles / Q000187:drug effects; D003042:Cocaine / Q000494:pharmacology; D000242:Cyclic AMP / Q000096:biosynthesis*; D005459:Fluorides / Q000494:pharmacology; D006892:Hydroxydopamines / Q000008:administration & dosage / Q000494:pharmacology*; D066298:In Vitro Techniques; D007267:Injections; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009410:Nerve Degeneration / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors; D014316:Tritium
D002250:Carbon Radioisotopes; D002395:Catecholamines; D006892:Hydroxydopamines; D014316:Tritium; D000242:Cyclic AMP; D003042:Cocaine; D007545:Isoproterenol; D005459:Fluorides; D009638:Norepinephrine